Important note for merchants

Baldev Malhotra : Tomorrow is the date of 01-06-2017 GST Migration and DSC uploading process for 15 days. So all dealers should use this opportunity. It has already been sent to GSTIN (Provisional I D) dealers to their mobile phones and emails. Please note that both of these will be checked and processed through the GST migration process. Please note that the GST migration must have happened if the dealer who needs to get ITC (Input Tax Credit) in GST.

Start from tomorrow. So that the migration process is done quickly. Combine your accountant with them today.

The merchant shall upload the information to VATIS as per the ANneXURE III and IV of the Quarter ending 31-03-2017 and to the end of 30-06-2017. This information is requested to be uploaded immediately.
MR. M. RAMA KRISHNA RAO
HON GEN. SECRETARY
SEEMA ANDHRA DRUG DEALERS ASSO.

gstn-migration-process-9-638

medicare coming soon

  • Related Posts

    MedTech Zone AMTZ Puts Vizag on the Science Map of India

    Vizag Science &Technology Cluster rated as one of the India’s Strategic Innovation Hubs Visakhapatnam, June 28 – In a significant boost to Vizag’s growing scientific stature, the Andhra Pradesh MedTech…

    • News
    • May 27, 2025
    • 269 views
    Ramping Up Community for JeevanRaksha during Disasters

    CBDM India 2025 will Champion Health Resilience and Local Response Bengaluru: As India and its neighbours continue to confront the double threat of increasing natural disasters and unpredictable man-made crises—including…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    India’s Glenmark Pharma unit, AbbVie sign exclusive licensing pact

    India’s Glenmark Pharma unit, AbbVie sign exclusive licensing pact

    Very Arty Surgery for Weight Loss by SSI Mantra, World’s First

    Very Arty Surgery for Weight Loss by SSI Mantra, World’s First

    Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

    Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

    Novartis wins approval for first malaria drug for newborns and babies

    Novartis wins approval for first malaria drug for newborns and babies